The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on ^sup 18^F-FDG Uptake of Primary Breast Cancer Lesions
The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before unde...
Saved in:
Published in | The Journal of nuclear medicine (1978) Vol. 48; no. 8; p. 1266 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York
Society of Nuclear Medicine
01.08.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson X2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, x2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (x2 = 71.054,P< 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (x2 = 13.026, P < 0.01 ). No relationship was detected between PR and C-erbB-2R states (?2 = 3.695, P > 0.05). ANOVAs showed that PR state atañe (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18FFDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. [PUBLICATION ABSTRACT] |
---|---|
AbstractList | The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson X2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, x2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (x2 = 71.054,P< 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (x2 = 13.026, P < 0.01 ). No relationship was detected between PR and C-erbB-2R states (?2 = 3.695, P > 0.05). ANOVAs showed that PR state atañe (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18FFDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. [PUBLICATION ABSTRACT] |
Author | Mavi, Ayse Cermik, Tevfik F Urhan, Muammer Puskulcu, Halis |
Author_xml | – sequence: 1 givenname: Ayse surname: Mavi fullname: Mavi, Ayse – sequence: 2 givenname: Tevfik surname: Cermik middlename: F fullname: Cermik, Tevfik F – sequence: 3 givenname: Muammer surname: Urhan fullname: Urhan, Muammer – sequence: 4 givenname: Halis surname: Puskulcu fullname: Puskulcu, Halis |
BookMark | eNqNjc1uwjAQhC0EUgP0HVY9Y8kOOIQrISkHDoifK8hNNy1Q7LDrHJD68ASpD9DTd5iZb_qi67zDjoi0GRtpkmTaFZHSiZbGKPMi-sxnpVSSpmkkfnffCHlVYRkYfAU5B_Jf6EawfpIDUisbgXWfkEmkj7mMYYMl1sETbIMN2O4cHLipQaeHQhaLd9jXwV7w6VvT6WrpDnNCywEy60okWCGfvOOh6FX2h_H1jwPxVuS7bClr8remPT-efUOujY6xnsWTyWxqxv8qPQBfgE7w |
CODEN | JNMEAQ |
ContentType | Journal Article |
Copyright | Copyright Society of Nuclear Medicine Aug 2007 |
Copyright_xml | – notice: Copyright Society of Nuclear Medicine Aug 2007 |
DBID | 3V. 4T- 7RV 7X7 7XB 88E 88I 8AF 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M2P M7P M7Z NAPCQ P5Z P62 P64 PQEST PQQKQ PQUKI Q9U S0X |
DatabaseName | ProQuest Central (Corporate) Docstoc Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Biological Science Database Biochemistry Abstracts 1 Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic SIRS Editorial |
DatabaseTitle | ProQuest Central Student Technology Collection Technology Research Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Docstoc Biochemistry Abstracts 1 ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest Central Student |
Database_xml | – sequence: 1 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-5667 |
ExternalDocumentID | 1322000381 |
GroupedDBID | --- -~X .55 .GJ 29L 2WC 3V. 4T- 53G 5RE 7RV 7X7 7XB 88E 88I 8AF 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8R4 8R5 8WZ A6W ABSQV ABUWG ACGOD ACIWK ACPRK ADDZX AENEX AFFNX AFKRA AFOSN AFRAH AHMBA AI. ALIPV ALMA_UNASSIGNED_HOLDINGS ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EMOBN EX3 F5P F9R FR3 FYUFA GNUQQ H13 HCIFZ HMCUK I-F IL9 INIJC K9. KQ8 L7B LK8 M1P M2P M2Q M7P M7Z N4W NAPCQ OK1 P2P P62 P64 PQEST PQQKQ PQUKI PROAC PSQYO Q2X Q9U R0Z RHF RHI RNS RWL S0X SJN SV3 TAE TR2 TSM UKHRP VH1 W8F WH7 WOQ WOW X7M YHG |
ID | FETCH-proquest_journals_2192449753 |
IEDL.DBID | BENPR |
ISSN | 0161-5505 |
IngestDate | Thu Oct 10 22:40:19 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-proquest_journals_2192449753 |
PQID | 219244975 |
PQPubID | 40808 |
ParticipantIDs | proquest_journals_219244975 |
PublicationCentury | 2000 |
PublicationDate | 20070801 |
PublicationDateYYYYMMDD | 2007-08-01 |
PublicationDate_xml | – month: 08 year: 2007 text: 20070801 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | The Journal of nuclear medicine (1978) |
PublicationYear | 2007 |
Publisher | Society of Nuclear Medicine |
Publisher_xml | – name: Society of Nuclear Medicine |
SSID | ssj0006888 |
Score | 3.7719665 |
Snippet | The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and... |
SourceID | proquest |
SourceType | Aggregation Database |
StartPage | 1266 |
SubjectTerms | Biopsy Breast cancer Health Insurance Portability & Accountability Act 1996-US Health services Medical treatment Metabolism Patients Progesterone Studies Tissues Tumors |
Title | The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on ^sup 18^F-FDG Uptake of Primary Breast Cancer Lesions |
URI | https://www.proquest.com/docview/219244975 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa8IwED6mwtjL2E-2uckx9mhYW1PbPo3pWmVMkTHBJyVZ0xeh7Wx92x-_XBt9GfiSPATCkS_cfXe53AE82X7MXUvGzO7ZCaNqIEwqKVjQ16MtFOcBfRSeTPvjOX9fuAuTm1OYtMqdTqwUdZx9U4z82SFPgQee-5L_MGoaRY-rpoNGA1qOdhSsJrQG4XT2uVfFfb9qPEm0hhEV_6dwKysSncGpoX_4WuN1DkcqvYDjiXngvoRfDRvWFYULzBIMi3KTaYy7OKOZqhpkqeqi9v9xyPSRDJiDmvqpXPvOWDNHzFJcFtscbX8ZsehthPO8FGtF-83q4hI4oFz0EoeE-QY_FMXMiit4jMKv4ZjtpF-Zm1as9ufSu4ZmqkW4AbSSxEo8xWNHSC57wtdik2kWtgyE78W30D6w0d3B1Tac1OFNyoG7h2a52aoHbZdL2YGGt_D06EejjkHiD0Yul2U |
link.rule.ids | 315,783,787,12068,12777,21400,31731,33385,33756,43322,43612,43817,74079,74369,74636 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5BkYAF8RRQHifEWIs6cZtkQrQ0FGiqDq2UqZVNnAUpCU268ePxJWkXpC72YMk6-bPu5fN3AI_cjUSnrSLGbR4zYgNhSivJvK4ZudRCePRROBh3hzPxEXbCujYnr8sq1zqxVNRR-kU58ieLIgXhOZ3n7IdR0yh6XK07aOzCHtFwUQMDJ9zEW9ROxa2ovTkjR_yfui1tiH8MR7Xzhy8VWiewo5NT2A_q5-0z-DWgYcUnnGMa4yAvlqlBuIUTmonTIE10C030j31mDqTHLDSOn85M5IyV34hpgvN8lSF35z7zX99wlhXyW9N-k4paAntUiV5gnxBf4khTxiw_hwd_MO0P2Vr6RX3P8sXmVOwLaCRGhEvAdhy3Y0eLyJJKKFu6RmwyzJIrT7pOdAXNLRtdb129h4PhNBgtRu_jzyYcVolOqoa7gUaxXOlbY6ELdVfi8AfdO5cj |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5BkSoWxFNAeZwQY602jZvHhOgjLdBWGajUqZVNnAUpCU268ePxJW4XpC7OYMk6-bPuPp8v3wE8W17Eu20ZMcu2YkZqIEwqKZjv6NESinOffhSezpzxnL8vugsjKZSbssqtTywddZR-UY681aGbAvfdbis2VRHhIHjJfhg1kKKHVtNN4xCOdFB06IB7wWjnlB2vbEFJBIcRKf_nest4EpzCiSGC-FohdwYHKjmH-tQ8dV_ArwYQK23hHNMYh3mxTjXaTQzpS_oGaaKaKJII-0xvTo91UJNAlelbNFYcEtMEl_kmQ8tbBiwYjHCeFeJb0XphJTOBPapKL7BP6K9xoih7ll_CUzD87I_Z1vqVOXP5ardD9hXUEm3CNWA7jtuxq3jUEZJLW3jabArSwpK-8NzoBhp7FrrdO_sIdQ3BavI2-2jAcZXzpMK4O6gV642618G6kA8lDH9K0Jth |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Effects+of+Estrogen%2C+Progesterone%2C+and+C-erbB-2+Receptor+States+on+%5Esup+18%5EF-FDG+Uptake+of+Primary+Breast+Cancer+Lesions&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Mavi%2C+Ayse&rft.au=Cermik%2C+Tevfik+F&rft.au=Urhan%2C+Muammer&rft.au=Puskulcu%2C+Halis&rft.date=2007-08-01&rft.pub=Society+of+Nuclear+Medicine&rft.issn=0161-5505&rft.eissn=1535-5667&rft.volume=48&rft.issue=8&rft.spage=1266&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1322000381 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon |